Cardinal Health (NYSE: CAH), Dublin, Ohio, distributor of pharmaceuticals and medical and laboratory products, reported sales for its fiscal 2022 fourth quarter ended June 30, 2022, were $47.1 billion, up 11% from the prior-year period.
Net profit for the fourth quarter was $138 million, up 19% from the prior-year period. Cardinal also reported its total-year sales for 2022 were $181.4 billion, up 12% from 2021. Net loss for the total year was $933 million.
“In fiscal year 2022, Medical segment performance was significantly impacted by inflation and supply chain constraints,” said Mike Kauffman, CEO. “In addition, the Pharmaceutical segment grew 5% and we generated strong cash flow, returning $1.6 billion to our shareholders through share repurchases and dividends.”